A University of Liverpool researcher dedicated to tackling the urgent issue of antimicrobial resistance (AMR) has joined a major new international consortium formed to accelerate antibiotic discovery.
The Gates Foundation, Novo Nordisk Foundation, and Wellcome has awarded $60 million in new grant funding over the next three years to research teams around the world exploring novel approaches to antibiotic discovery to deal with the growing threat of antimicrobial resistance (AMR).
The Gram-Negative Antibiotic Discovery Innovator (Gr‑ADI) consortium will unite partners across 17 countries and 18 projects. Among these is a major initiative led by Professor William Hope
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
